Assessment of Bone Mineral Status in Children With Marfan Syndrome

被引:24
作者
Grover, Monica [2 ]
Brunetti-Pierri, Nicola [1 ]
Belmont, John [1 ]
Phan, Kelly [1 ]
Tran, Alyssa [1 ]
Shypailo, Roman J. [3 ]
Ellis, Kenneth J. [3 ]
Lee, Brendan H. [1 ,4 ]
机构
[1] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Pediat Diabet & Endocrinol, Houston, TX 77030 USA
[3] Baylor Coll Med, Childrens Nutr Res Ctr, Houston, TX 77030 USA
[4] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
Marfan syndrome; bone mineral density; TGF-beta; TGF-BETA; AORTIC-ANEURYSM; POSTMENOPAUSAL WOMEN; FRACTURE RISK; DENSITY; BLOCKERS; PATHOGENESIS; CONTRIBUTES; INHIBITION; RESORPTION;
D O I
10.1002/ajmg.a.35540
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Marfan syndrome (MFS) is an autosomal dominant connective tissue disorder with skeletal involvement. It is caused by mutations in fibrillin1 (FBN1) gene resulting in activation of TGF-beta, which developmentally regulates bone mass and matrix properties. There is no consensus regarding bone mineralization in children with MFS. Using dual-energy X-ray absorptiometry (DXA), we evaluated bone mineralization in 20 children with MFS unselected for bone problems. z-Scores were calculated based on age, gender, height, and ethnicity matched controls. Mean whole body bone mineral content (BMC) z-score was 0.26 +/- 1.42 (P = 0.41). Mean bone mineral density (BMD) z-score for whole body was -0.34 +/- 1.4 (P = 0.29) and lumbar spine was reduced at -0.55 +/- 1.34 (P = 0.017). On further adjusting for stature, which is usually higher in MFS, mean BMC z-score was reduced at -0.677 +/- 1.37 (P = 0.04), mean BMD z-score for whole body was -0.82 +/- 1.55 (P = 0.002) and for lumbar spine was -0.83 +/- 1.32 (P = 0.001). An increased risk of osteoporosis in MFS is controversial. DXA has limitations in large skeletons because it tends to overestimate BMD and BMC. By adjusting results for height, age, gender, and ethnicity, we found that MFS patients have significantly lower BMC and BMD in whole body and lumbar spine. Evaluation of diet, exercise, vitamin D status, and bone turnover markers will help gain insight into pathogenesis of the reduced bone mass. Further, larger longitudinal studies are required to evaluate the natural history, incidence of fractures, and effects of pharmacological therapy. (C) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:2221 / 2224
页数:4
相关论文
共 36 条
[1]   Bone biopsy and densitometry findings in a child with Camurati-Engelmann disease [J].
Bondestam, Jonas ;
Mayranpaa, Mervi K. ;
Ikegawa, Shiro ;
Marttinen, Eino ;
Kroger, Heikki ;
Makitie, Outi .
CLINICAL RHEUMATOLOGY, 2007, 26 (10) :1773-1777
[2]   Protective effect of β blockers in postmenopausal women:: Influence on fractures, bone density, micro and macroarchitecture [J].
Bonnet, N. ;
Gadois, C. ;
McCloskey, E. ;
Lemineur, G. ;
Lespessailles, E. ;
Courteix, D. ;
Benhamou, C. L. .
BONE, 2007, 40 (05) :1209-1216
[3]   Determination of the molecular basis of Marfan syndrome: a growth industry [J].
Byers, PH .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (02) :161-163
[4]   Bone mineral density in adults with Marfan syndrome [J].
Carter, N ;
Duncan, E ;
Wordsworth, P .
RHEUMATOLOGY, 2000, 39 (03) :307-309
[5]   MARFAN-SYNDROME CAUSED BY A RECURRENT DENOVO MISSENSE MUTATION IN THE FIBRILLIN GENE [J].
DIETZ, HC ;
CUTTING, GR ;
PYERITZ, RE ;
MASLEN, CL ;
SAKAI, LY ;
CORSON, GM ;
PUFFENBERGER, EG ;
HAMOSH, A ;
NANTHAKUMAR, EJ ;
CURRISTIN, SM ;
STETTEN, G ;
MEYERS, DA ;
FRANCOMANO, CA .
NATURE, 1991, 352 (6333) :337-339
[6]   Inhibition of TGF-β Signaling by 1D11 Antibody Treatment Increases Bone Mass and Quality In Vivo [J].
Edwards, James R. ;
Nyman, Jeffry S. ;
Lwin, Seint T. ;
Moore, Megan M. ;
Esparza, Javier ;
O'Quinn, Elizabeth C. ;
Hart, Andrew J. ;
Biswas, Swati ;
Patil, Chetan A. ;
Lonning, Scott ;
Mahadevan-Jansen, Anita ;
Mundy, Gregory R. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2010, 25 (11) :2419-2426
[7]   Z score prediction model for assessment of bone mineral content in pediatric diseases [J].
Ellis, KJ ;
Shypailo, RJ ;
Hardin, DS ;
Perez, MD ;
Motil, KJ ;
Wong, WW ;
Abrams, SA .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (09) :1658-1664
[8]   Assessment of bone mineral density in adults and children with Marfan syndrome [J].
Giampietro, PF ;
Peterson, M ;
Schneider, R ;
Davis, JG ;
Raggio, C ;
Myers, E ;
Burke, SW ;
Boachie-Adjei, O ;
Mueller, CM .
OSTEOPOROSIS INTERNATIONAL, 2003, 14 (07) :559-563
[9]  
Giampietro Philip F, 2007, HSS J, V3, P89, DOI 10.1007/s11420-006-9030-3
[10]   OSTEOPOROSIS AND THE MARFAN-SYNDROME [J].
GRAY, JR ;
BRIDGES, AB ;
MOLE, PA ;
PRINGLE, T ;
BOXER, M ;
PATERSON, CR .
POSTGRADUATE MEDICAL JOURNAL, 1993, 69 (811) :373-375